Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'
- PMID: 35699658
- DOI: 10.1111/ced.15291
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'
Comment on
-
Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?Clin Exp Dermatol. 2022 Aug;47(8):1585-1586. doi: 10.1111/ced.15232. Epub 2022 Jun 3. Clin Exp Dermatol. 2022. PMID: 35437813 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical